Stockscreener 앱 받기
70.44
1.48%
1.03
시간 외 거래:
70.44
전일 마감가:
$69.41
열려 있는:
$68.8
하루 거래량:
4.97M
Relative Volume:
3.13
시가총액:
$12.60B
수익:
$342.96M
순이익/손실:
$-864.29M
주가수익비율:
-13.37
EPS:
-5.27
순현금흐름:
$-636.03M
1주 성능:
-1.66%
1개월 성능:
-3.07%
6개월 성능:
+8.85%
1년 성능:
+154.20%
1일 변동 폭
$68.80
$71.07
1주일 범위
$68.67
$75.16
52주 변동 폭
$21.92
$80.53
Insmed Inc Stock (INSM) Company Profile
명칭
Insmed Inc
전화
908-977-9900
주소
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
INSM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
70.44 | 12.60B | 342.96M | -864.29M | -636.03M | -5.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-04-23 | 개시 | Truist | Buy |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2023-12-08 | 개시 | Wells Fargo | Overweight |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-07-26 | 개시 | Guggenheim | Buy |
| 2022-12-09 | 개시 | Mizuho | Buy |
| 2022-12-07 | 개시 | Barclays | Overweight |
| 2022-11-18 | 개시 | BofA Securities | Buy |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2021-12-06 | 개시 | JP Morgan | Overweight |
| 2021-10-19 | 재개 | Monness Crespi & Hardt | Buy |
| 2021-10-19 | 재개 | Morgan Stanley | Overweight |
| 2021-10-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2020-12-17 | 개시 | Berenberg | Buy |
| 2020-10-12 | 재개 | Stifel | Buy |
| 2019-09-03 | 개시 | Goldman | Buy |
| 2019-04-09 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-15 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-01-02 | 개시 | Canaccord Genuity | Buy |
| 2018-08-06 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | 개시 | Goldman | Neutral |
| 2018-04-23 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | 개시 | Morgan Stanley | Overweight |
| 2018-01-18 | 개시 | Credit Suisse | Neutral |
| 2017-09-05 | 재확인 | Evercore ISI | Outperform |
| 2017-08-17 | 개시 | Evercore ISI | Outperform |
| 2017-07-11 | 개시 | Robert W. Baird | Outperform |
| 2016-03-15 | 개시 | Stifel | Buy |
| 2015-11-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2015-10-06 | 재확인 | H.C. Wainwright | Buy |
| 2015-06-09 | 개시 | Citigroup | Neutral |
| 2014-03-26 | 재확인 | HC Wainwright | Buy |
모두보기
Insmed Inc 주식(INSM)의 최신 뉴스
Principal Financial Group Inc. Has $136.65 Million Holdings in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insider Selling: Insmed Incorporated (NASDAQ:INSM) CEO Sells 18,750 Shares of Stock - MarketBeat
Insmed CEO William Lewis sells $1.79 million in stock - Investing.com
Insmed's SWOT analysis: biopharmaceutical firm's stock poised for growth amid challenges - Investing.com
Tidal Investments LLC Buys 19,696 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Geode Capital Management LLC Purchases 172,664 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed CEO William Lewis sells $1.87 million in stock - Investing.com India
Insmed CEO William Lewis sells $1.87 million in stock By Investing.com - Investing.com Australia
Pulmonary Arterial Hypertension Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Novartis, Insmed Inc, Chugai Pharma, Merck Sharp & Dohme, Janssen Pharma, Aerovate - The Globe and Mail
Analysts Set Insmed Incorporated (NASDAQ:INSM) PT at $83.67 - MarketBeat
Insmed Incorporated (NASDAQ:INSM) Position Increased by Orion Portfolio Solutions LLC - MarketBeat
Insmed's SWOT analysis: rare disease biotech stock poised for growth By Investing.com - Investing.com Canada
Insmed's SWOT analysis: rare disease biotech stock poised for growth - Investing.com
Wellington Management Group LLP Purchases 24,025 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Citizentribune
Should You Invest in Insmed Incorporated (INSM)? - Insider Monkey
Insmed Incorporated (NASDAQ:INSM) Shares Acquired by Castleark Management LLC - MarketBeat
Insmed To Present at December 2024 Investor Conferences - Citizentribune
Soros Fund Management LLC Buys 7,901 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Point72 Asset Management L.P. Sells 5,552,949 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed (LTS:0JAV) Price-to-Operating-Cash-Flow : (As of Dec. 05, 2024) - GuruFocus.com
Readystate Asset Management LP Reduces Position in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
RTW Investments LP Decreases Position in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed Incorporated (NASDAQ:INSM) Shares Purchased by Polar Asset Management Partners Inc. - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Cuts Stock Holdings in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
INSM (Insmed) Price-to-Operating-Cash-Flow : (As of Dec. 05, 2024) - GuruFocus.com
Parkman Healthcare Partners LLC Has $2.59 Million Stock Holdings in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Patient Square Capital LP Makes New $12.53 Million Investment in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Bamco Inc. NY Takes Position in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Cerity Partners LLC Buys 17,869 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed Incorporated (NASDAQ:INSM) Stake Reduced by HighVista Strategies LLC - MarketBeat
Cinctive Capital Management LP Sells 114,851 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Erste Asset Management GmbH Buys New Position in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Why Is Insmed Incorporated (INSM) Among the Best High Growth Healthcare Stocks to Invest In Now? - Insider Monkey
Insmed to Present at Evercore ISI HealthCONx and Nasdaq Investor Conferences - StockTitan
Bellevue Group AG Reduces Holdings in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed (LTS:0JAV) Forward Dividend Yield % : 0.00% (As of Nov. 30, 2024) - GuruFocus.com
Eventide Asset Management LLC Grows Stock Holdings in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Vestal Point Capital LP Purchases 850,000 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed Incorporated (NASDAQ:INSM) is Suvretta Capital Management LLC's 3rd Largest Position - MarketBeat
Groundbreaking Insights Unveiled in Non-Cystic Fibrosis Bronchiectasis Pipeline Report - GlobeNewswire Inc.
Insmed Incorporated (NASDAQ:INSM) Shares Bought by Ally Bridge Group NY LLC - MarketBeat
Insmed Incorporated (NASDAQ:INSM) is Acuta Capital Partners LLC's 4th Largest Position - MarketBeat
Insmed Insiders Sold US$3.8m Of Shares Suggesting Hesitancy - Simply Wall St
Charles Schwab Investment Management Inc. Raises Stake in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Qsemble Capital Management LP Takes $1.69 Million Position in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Natixis Advisors LLC Makes New $1.53 Million Investment in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed (LTS:0JAV) 3-Year Revenue Growth Rate : 8.90% (As of Sep. 2024) - GuruFocus.com
Insmed Incorporated (NASDAQ:INSM) Shares Sold by Loomis Sayles & Co. L P - MarketBeat
Westfield Capital Management Co. LP Makes New $18.38 Million Investment in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Intech Investment Management LLC Buys New Shares in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed Inc (INSM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Insmed Inc 주식 (INSM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Lewis William | Chair and CEO |
Dec 19 '24 |
Option Exercise |
10.85 |
6,830 |
74,106 |
240,754 |
| Lewis William | Chair and CEO |
Dec 19 '24 |
Sale |
69.91 |
18,750 |
1,310,799 |
384,960 |
| Lewis William | Chair and CEO |
Dec 19 '24 |
Sale |
69.92 |
6,830 |
477,550 |
233,924 |
2.88%
2.65%
자본화:
|
볼륨(24시간):